Clinical and molecular analyses of NEONAB: a phase II trial of breast cancer patients treated with neoadjuvant epirubicin, cyclophosphamide and nab-paclitaxel
Murphy, Caitlin 2018, Clinical and molecular analyses of NEONAB: a phase II trial of breast cancer patients treated with neoadjuvant epirubicin, cyclophosphamide and nab-paclitaxel, M.App.Sc. (Medicine) thesis, School of Medicine, Deakin University.
Clinical and molecular analyses of NEONAB: a phase II trial of breast cancer patients treated with neoadjuvant epirubicin, cyclophosphamide and nab-paclitaxel
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO.
If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.